menu
    • menu

    Company profile for NervGen Pharma

    NEW Drugs in Dev: 2
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    NervGen is a publicly traded (TSX-V: NGEN, OTCQX: NGENF) clinical stage biotech company dedicated to discovering and developing innovative treatments for nervous system damage, due to injury or disease. NervGen’s lead drug candidate, NVG-291, is a first of its kind experimental drug administered by injection under the skin. NVG-291 relieves the inhibitory effects of CSPGs and thus enables nervous system repair. In animal...
    NervGen is a publicly traded (TSX-V: NGEN, OTCQX: NGENF) clinical stage biotech company dedicated to discovering and developing innovative treatments for nervous system damage, due to injury or disease. NervGen’s lead drug candidate, NVG-291, is a first of its kind experimental drug administered by injection under the skin. NVG-291 relieves the inhibitory effects of CSPGs and thus enables nervous system repair. In animal studies, this therapeutic approach promoted nervous system repair and enhanced recovery of functions such as walking, bladder control, vision, and memory.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NervGen PharmaCanada Flag
    Country
    Country
    Canada
    Address
    Address
    2955 Virtual Way Suite 480 Vancouver, BC V5M 4X6
    Telephone
    Telephone
    (778) 731-1711
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nervgen.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nervgen/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/NervgenP

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    AMWC Asia-TDAC

    AMWC Asia-TDAC

    Not Confirmed

    envelop Contact Supplier

    AMWC Asia-TDAC

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Nervgen Pharma Joins H.C. Wainwright And Bloom Burton Health Conf
    Nervgen Pharma Joins H.C. Wainwright And Bloom Burton Health Conf

    13 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/13/3272409/0/en/NervGen-Pharma-to-Participate-in-the-H-C-Wainwright-HCW-Home-Series-and-the-2026-Bloom-Burton-Co-Healthcare-Investor-Conference.html

    GLOBENEWSWIRE
    13 Apr 2026
    Share Share
    NervGen Pharma Reveals 2025 Financials And Business Updates
    NervGen Pharma Reveals 2025 Financials And Business Updates

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3265362/0/en/NervGen-Pharma-Reports-Full-Year-2025-Financial-Results-and-Provides-Business-Updates.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    NervGen Pharma Voluntarily Delists From TSX Venture Exchange
    NervGen Pharma Voluntarily Delists From TSX Venture Exchange

    12 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/12/3255138/0/en/NervGen-Pharma-Announces-Voluntary-Delisting-from-TSX-Venture-Exchange.html

    GLOBENEWSWIRE
    12 Mar 2026
    Share Share
    NervGen Names Ruff Chief Regulatory Affairs Officer, McSherry SVP
    NervGen Names Ruff Chief Regulatory Affairs Officer, McSherry SVP

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249258/0/en/NervGen-Pharma-Appoints-Shamim-Ruff-as-Chief-Regulatory-Affairs-Officer-and-Christine-McSherry-as-SVP-Patient-Advocacy-and-Clinical-Affairs.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    Nervgen Pharma To Participate At Upcoming Investor Conferences
    Nervgen Pharma To Participate At Upcoming Investor Conferences

    18 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/18/3240099/0/en/NervGen-Pharma-to-Participate-at-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    18 Feb 2026
    Share Share
    NervGen Announces Retirement of CFO, Bill Adams
    NervGen Announces Retirement of CFO, Bill Adams

    12 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/12/3237692/0/en/NervGen-Pharma-Announces-Retirement-of-Chief-Financial-Officer-Bill-Adams.html

    GLOBENEWSWIRE
    12 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search